384 related articles for article (PubMed ID: 12813006)
21. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
[TBL] [Abstract][Full Text] [Related]
23. Differences in puromycin aminonucleoside nephrosis in two rat strains.
Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
[TBL] [Abstract][Full Text] [Related]
24. In glomerular cells of puromycin aminonucleoside nephrosis rats both phosphorylated and total STAT3 levels increased during proteinuria.
Saygı Hİ; Güngör ZB; Kalay F; Seçkin İ
Acta Histochem; 2018 Aug; 120(6):595-603. PubMed ID: 30054017
[TBL] [Abstract][Full Text] [Related]
25. Glomerular podocyte cell junctions in nephrotic syndrome. I. Freeze-fracture studies in rat aminonucleoside nephrosis.
Kühn K; Sterzel RB; Reale E
J Submicrosc Cytol; 1981 Jul; 13(3):407-12. PubMed ID: 7334544
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of connexin43 in glomerular podocytes in response to injury.
Yaoita E; Yao J; Yoshida Y; Morioka T; Nameta M; Takata T; Kamiie J; Fujinaka H; Oite T; Yamamoto T
Am J Pathol; 2002 Nov; 161(5):1597-606. PubMed ID: 12414508
[TBL] [Abstract][Full Text] [Related]
27. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
Whiteside C; Prutis K; Cameron R; Thompson J
Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
29. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
31. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
32. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
[TBL] [Abstract][Full Text] [Related]
33. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
Shinosaki T; Takagawa I; Sunagawa N; Yonetani Y; Kurihara H
Jpn J Pharmacol; 1997 Apr; 73(4):337-45. PubMed ID: 9165371
[TBL] [Abstract][Full Text] [Related]
34. Renal structural abnormalities following recovery from acute puromycin nephrosis.
Rasch R; Nyengaard JR; Marcussen N; Meyer TW
Kidney Int; 2002 Aug; 62(2):496-506. PubMed ID: 12110010
[TBL] [Abstract][Full Text] [Related]
35. Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
Kino J; Tsuji S; Kitao T; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
Pediatr Res; 2018 May; 83(5):1041-1048. PubMed ID: 29360807
[TBL] [Abstract][Full Text] [Related]
36. Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis.
Dunér F; Lindström K; Hultenby K; Hulkko J; Patrakka J; Tryggvason K; Haraldsson B; Wernerson A; Pettersson E
Nephron Exp Nephrol; 2010; 116(2):e42-52. PubMed ID: 20588063
[TBL] [Abstract][Full Text] [Related]
37. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis.
Shiiki H; Sasaki Y; Nishino T; Kimura T; Kurioka H; Fujimoto S; Dohi K
Pathobiology; 1998; 66(5):221-9. PubMed ID: 9732237
[TBL] [Abstract][Full Text] [Related]
38. Increased apoptosis in acute puromycin aminonucleoside nephrosis.
Fernandez L; Romero M; Soto H; Mosquera J
Exp Nephrol; 2001; 9(2):99-108. PubMed ID: 11150858
[TBL] [Abstract][Full Text] [Related]
39. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
Radin MJ; Wilke WL; Fettman MJ
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
[TBL] [Abstract][Full Text] [Related]
40. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
